Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ironwood Pharmaceuticals (IRWD) EPS (Weighted Average and Diluted) (2018 - 2025)

Historic EPS (Weighted Average and Diluted) for Ironwood Pharmaceuticals (IRWD) over the last 13 years, with Q3 2025 value amounting to $0.23.

  • Ironwood Pharmaceuticals' EPS (Weighted Average and Diluted) rose 105000.0% to $0.23 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.15, marking a year-over-year increase of 60000.0%. This contributed to the annual value of $0.01 for FY2024, which is 10015.5% up from last year.
  • As of Q3 2025, Ironwood Pharmaceuticals' EPS (Weighted Average and Diluted) stood at $0.23, which was up 105000.0% from $0.14 recorded in Q2 2025.
  • Ironwood Pharmaceuticals' 5-year EPS (Weighted Average and Diluted) high stood at $2.39 for Q2 2021, and its period low was -$6.84 during Q2 2023.
  • In the last 5 years, Ironwood Pharmaceuticals' EPS (Weighted Average and Diluted) had a median value of $0.21 in 2022 and averaged -$0.11.
  • Per our database at Business Quant, Ironwood Pharmaceuticals' EPS (Weighted Average and Diluted) tumbled by 335714.29% in 2023 and then soared by 150000.0% in 2025.
  • Ironwood Pharmaceuticals' EPS (Weighted Average and Diluted) (Quarter) stood at $0.25 in 2021, then increased by 8.0% to $0.27 in 2022, then tumbled by 103.7% to -$0.01 in 2023, then surged by 200.0% to $0.01 in 2024, then soared by 2200.0% to $0.23 in 2025.
  • Its EPS (Weighted Average and Diluted) stands at $0.23 for Q3 2025, versus $0.14 for Q2 2025 and -$0.23 for Q1 2025.